Rivastigmine in the Treatment of Postoperative Delirium: a Pilot Clinical Trial
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether preoperative administration of Rivastigmine
prevents the incidence of postoperative delirium in patients undergoing major surgery as well
as postoperative cognitive dysfunction.
Phase:
Phase 4
Details
Lead Sponsor:
New York University School of Medicine NYU Langone Health